Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCEIF3.22020-03-019OAAI
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal InfectionBIOMEDICINESIF3.92017-11-2013OAAI
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infectionsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62017-10-253OAAI
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samplesJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12017-10-0120PREAI
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children伏立康唑治疗和预防儿童侵袭性真菌感染的治疗药物监测BRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32017-09-2446OAAI
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32017-01-183OAAI
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic studyINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22016-01-0110PREAI
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapyBIOMEDICINE & PHARMACOTHERAPYIF7.52015-02-0112PREAI